Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Concurrent Chemoradiotherapy for High-Risk Salivary Gland Carcinomas
NCT02776163Phase 2Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Jun 2016
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of nedaplatin, docetaxel in salivary gland carcinoma (SGC), sponsored by Shanghai Ninth People's Hospital. Started Jun 2016; status: completed.
02
Drugs
nedaplatindocetaxel
03
Conditions
salivary gland carcinoma (SGC)
Beyond the preview
Go deeper on NCT02776163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776163.